Qube Research & Technologies (QRT)
BMY icon

Qube Research & Technologies (QRT)’s Bristol-Myers Squibb BMY Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.1M Sell
463,600
-529,400
-53% -$30.9M 0.03% 687
2025
Q4 		$53.6M Sell
993,000
-122,100
-11% -$5.87M 0.05% 455
2025
Q3 		$50.3M Buy
1,115,100
+27,300
+3% +$1.27M 0.05% 460
2025
Q2 		$50.4M Buy
1,087,800
+296,200
+37% +$14.5M 0.05% 465
2025
Q1 		$48.3M Sell
791,600
-345,600
-30% -$20.1M 0.06% 421
2024
Q4 		$64.3M Buy
1,137,200
+144,000
+14% +$8.05M 0.08% 299
2024
Q3 		$51.4M Sell
993,200
-1,017,300
-51% -$47.7M 0.08% 342
2024
Q2 		$83.5M Buy
2,010,500
+406,600
+25% +$18.2M 0.13% 179
2024
Q1 		$87M Buy
1,603,900
+980,000
+157% +$49.9M 0.14% 180
2023
Q4 		$32M Buy
623,900
+358,000
+135% +$18.8M 0.06% 377
2023
Q3 		$15.4M Buy
265,900
+265,000
+29,444% +$16.2M 0.04% 486
2023
Q2 		$57.6K Hold
900
– – ﹤0.01% 2051
2023
Q1 		$62.4K Buy
+900
New +$63.5K ﹤0.01% 2200

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BMY Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Bristol-Myers Squibb (BMY) stake by 32% in Q1 2026, buying an estimated $45M and bringing the position to 3,203,665 shares worth $194M. The position accounts for 0.22% of the portfolio, ranked #96.

Qube Research & Technologies (QRT) first reported a position in BMY in Q1 2018 and has held it in 22 quarters since. The position peaked at $451M in Q2 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Qube Research & Technologies (QRT) held 3,203,665 shares of Bristol-Myers Squibb worth $194M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 772,565 Bristol-Myers Squibb shares in Q1 2026, an estimated $45M.
  • Bristol-Myers Squibb made up 0.22% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #96 holding.
  • Qube Research & Technologies (QRT) first reported a position in Bristol-Myers Squibb in Q1 2018 and has held it in 22 quarters since.
  • Qube Research & Technologies (QRT)'s Bristol-Myers Squibb position peaked at $451M in Q2 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.